Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination Product: mavrilimumab[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 41
2MAVRILIMUMAB[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 41, 46
3Mavrilimumab 10 mg[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46
4Mavrilimumab 100 mg[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46
5Mavrilimumab 150 mg[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46
6Mavrilimumab 30 mg[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46
7Mavrilimumab 50 mg[1] Mavrilimumab[1] D09930 (Name: Mavrilimumab)[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46